PharMerica - McKnight's Long Term Care News


Omnicare CEO John Figueroa

Rebuffed by PharMerica top brass, Omnicare appeals to board members in purchase attempt

Omnicare’s top management decided private negotiations with their counterparts at takeover target PharMerica were not working. So on Tuesday, Omnicare went public with an announced $15 per share bid for the company. The proposed deal would involve the No. 1 institutional pharmacy provider purchasing the No. 2 for $715 million, according to an Omnicare announcement.

Omnicare goes public with bid to buy rival PharMerica for $716 million

Omnicare, the biggest institutional pharmacy provider in the long-term care sector, publicly announced a $715 million bid for top rival PharMerica on Tuesday. Dissatisfied with the outcome of behind-doors talks over the past four months, Omnicare leaders decided to take their case directly to PharMerica board members.

Next post in News